Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

NCT00180947 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Rhabdomyosarcomas
Neoplasms, Connective and Soft Tissue
Ewing Tumor
Osteosarcomas
Neuroblastomas
Medulloblastomas

Interventions

DRUG: Vinorelbine, cyclofosfamide

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris